FoxP3- and CD8-positive infiltrating immune cells together determine clinical outcome in colorectal cancer

Cancer Microenvironment

Volumn 6, Issue 1, 2013, Pages 31-39

  Zeestraten, Eliane C M ^a   Van Hoesel, Anneke Q ^a   Speetjens, Frank M ^a   Menon, Anand G ^a   Putter, Hein ^a   Van De Velde, Cornelis J H ^a   Kuppen, Peter J K ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cancer prognosis; CD8; Colorectal cancer; FoxP3; Tumor immune infiltration

Indexed keywords

CD8 ANTIGEN; HLA ANTIGEN CLASS 1; TRANSCRIPTION FACTOR FOXP3;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL INFILTRATION; CELLULAR DISTRIBUTION; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENCE FREE SURVIVAL; STROMA; TUMOR EPITHELIUM;

EID: 84875250826     PISSN: 18752292     EISSN: 18752284     Source Type: Journal    
DOI: 10.1007/s12307-011-0071-x     Document Type: Article

References (29)

1. D Hanahan RA Weinberg 2011 Hallmarks of cancer: the next generation Cell 144 5 646 674 21376230 10.1016/j.cell.2011.02.013 1:CAS:528:DC%2BC3MXjsFeqtrk%3D
2. D Hanahan RA Weinberg 2000 The hallmarks of cancer Cell 100 1 57 70 10647931 10.1016/S0092-8674(00)81683-9 1:CAS:528:DC%2BD3cXks1CktA%3D%3D
3. H Ohtani 2007 Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human colorectal cancer Cancer Immun 7 4 17311363
4. Y Naito K Saito K Shiiba A Ohuchi K Saigenji H Nagura H Ohtani 1998 CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer Cancer Res 58 16 3491 3494 9721846 1:CAS:528: DyaK1cXlsFajsb4%3D
5. TB Halvorsen E Seim 1989 Association between invasiveness, inflammatory reaction, desmoplasia and survival in colorectal cancer J Clin Pathol 42 2 162 166 2921357 10.1136/jcp.42.2.162 1:STN:280:DyaL1M7lsFyluw%3D%3D
6. J Murphy GC O'Sullivan G Lee M Madden F Shanahan JK Collins IC Talbot 2000 The inflammatory response within Dukes' B colorectal cancers: implications for progression of micrometastases and patient survival Am J Gastroenterol 95 12 3607 3614 11151900 10.1111/j.1572-0241.2000.03377.x 1:STN:280: DC%2BD3M%2FpvFSksA%3D%3D
7. AG Menon CM Janssen-van Rhijn H Morreau H Putter RA Tollenaar CJ van de Velde GJ Fleuren PJ Kuppen 2004 Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis Lab Invest 84 4 493 501 14968119 10.1038/labinvest.3700055 1:CAS:528:DC%2BD2cXmtF2itrc%3D
8. Speetjens FM, de Bruin EC, Morreau H, Zeestraten EC, Putter H, van Krieken JH, van Buren MM, van VM, Dekker-Ensink NG, van de Velde CJ, Kuppen PJ (2008) Clinical Impact of HLA Class I Expression in Rectal Cancer. Cancer Immunol Immunother 57(5):601-9
9. EM de Kruijf JG van Nes A Sajet QR Tummers H Putter S Osanto FM Speetjens VT Smit GJ Liefers CJ van de Velde PJ Kuppen 2010 The predictive value of HLA class I tumor cell expression and presence of intratumoral tregs for chemotherapy in patients with early breast cancer Clin Cancer Res 16 4 1272 1280 20145162 10.1158/1078-0432.CCR-09-1844
10. TJ Curiel G Coukos L Zou X Alvarez P Cheng P Mottram M Evdemon-Hogan JR Conejo-Garcia L Zhang M Burow Y Zhu S Wei I Kryczek B Daniel A Gordon L Myers A Lackner ML Disis KL Knutson L Chen W Zou 2004 Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival Nat Med 10 9 942 949 15322536 10.1038/nm1093 1:CAS:528: DC%2BD2cXntFSkt7g%3D
11. N Hiraoka K Onozato T Kosuge S Hirohashi 2006 Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions Clin Cancer Res 12 18 5423 5434 17000676 10.1158/1078-0432.CCR-06-0369 1:CAS:528:DC%2BD28XpvFShsLc%3D
12. Q Gao SJ Qiu J Fan J Zhou XY Wang YS Xiao Y Xu YW Li ZY Tang 2007 Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection J Clin Oncol 25 18 2586 2593 17577038 10.1200/JCO.2006.09.4565
13. M Benevolo M Mottolese G Piperno I Sperduti A Cione L Sibilio A Martayan RP Donnorso M Cosimelli P Giacomini 2007 HLA-A, -B, -C expression in colon carcinoma mimics that of the normal colonic mucosa and is prognostically relevant Am J Surg Pathol 31 1 76 84 17197922 10.1097/01.pas.0000213343.55605.b9
14. P Moller F Momburg K Koretz G Moldenhauer C Herfarth HF Otto GJ Hammerling P Schlag 1991 Influence of major histocompatibility complex class I and II antigens on survival in colorectal carcinoma Cancer Res 51 2 729 736 1985791 1:STN:280:DyaK3M%2FptF2jsg%3D%3D
15. AG Menon H Morreau RA Tollenaar E Alphenaar PM Van H Putter CM Janssen-van Rhijn CJ van de Velde GJ Fleuren PJ Kuppen 2002 Down-regulation of HLA-A expression correlates with a better prognosis in colorectal cancer patients Lab Invest 82 12 1725 1733 12480922 1:CAS:528:DC%2BD38Xptlehtbs%3D
16. NF Watson JM Ramage Z Madjd I Spendlove IO Ellis JH Scholefield LG Durrant 2006 Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis Int J Cancer 118 1 6 10 16003753 10.1002/ijc.21303 1:CAS:528:DC%2BD2MXht1KgsrzJ
17. MH Sandel FM Speetjens AG Menon PA Albertsson PH Basse M Hokland JF Nagelkerke RA Tollenaar CJ van de Velde PJ Kuppen 2005 Natural killer cells infiltrating colorectal cancer and MHC class I expression Mol Immunol 42 4 541 546 15607811 10.1016/j.molimm.2004.07.039 1:CAS:528:DC%2BD2cXhtVyktrnF
18. M Hokland PJ Kuppen 2005 Natural killer cells: from " Disturbing" background to central players of immune responses Mol Immunol 42 4 381 383 15607788 10.1016/j.molimm.2004.07.016 1:CAS:528:DC%2BD2cXhtVyktrzF
19. E Sato SH Olson J Ahn B Bundy H Nishikawa F Qian AA Jungbluth D Frosina S Gnjatic C Ambrosone J Kepner T Odunsi G Ritter S Lele YT Chen H Ohtani LJ Old K Odunsi 2005 Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/Regulatory T cell ratio are associated with favorable prognosis in ovarian cancer Proc Natl Acad Sci USA 102 51 18538 18543 16344461 10.1073/pnas. 0509182102 1:CAS:528:DC%2BD28Xpt1Om
20. D Wolf AM Wolf H Rumpold H Fiegl AG Zeimet E Muller-Holzner M Deibl G Gastl E Gunsilius C Marth 2005 The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer Clin Cancer Res 11 23 8326 8331 16322292 10.1158/1078-0432.CCR- 05-1244 1:CAS:528:DC%2BD2MXht1KjsrnM
21. C Loddenkemper M Schernus M Noutsias H Stein E Thiel D Nagorsen 2006 In situ analysis of FOXP3+ regulatory T cells in human colorectal cancer J Transl Med 4 52 17166272 10.1186/1479-5876-4-52
22. H Suzuki N Chikazawa T Tasaka J Wada A Yamasaki Y Kitaura M Sozaki M Tanaka H Onishi T Morisaki M Katano 2010 Intratumoral CD8(+) T/FOXP3 (+) cell ratio is a predictive marker for survival in patients with colorectal cancer Cancer Immunol Immunother 59 5 653 661 19908042 10.1007/s00262-009-0781-9 1:CAS:528:DC%2BC3cXis1yhtro%3D
23. P Salama M Phillips F Grieu M Morris N Zeps D Joseph C Platell B Iacopetta 2009 Tumor-Infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer J Clin Oncol 27 2 186 192 19064967 10.1200/JCO.2008.18.7229
24. L Deng H Zhang Y Luan J Zhang Q Xing S Dong X Wu M Liu S Wang 2010 Accumulation of Foxp3+ T regulatory cells in draining lymph nodes correlates with disease progression and immune suppression in colorectal cancer patients Clin Cancer Res 16 16 4105 4112 20682706 10.1158/1078-0432.CCR-10-1073 1:CAS:528:DC%2BC3cXhtVajs7zL
25. RA Tollenaar JH van Krieken HJ van Slooten DJ Bruinvels KM Nelemans LJ van den Broek J Hermans JH van Dierendonck 1998 Immunohistochemical detection of P53 and Bcl-2 in colorectal carcinoma: no evidence for prognostic significance Br J Cancer 77 11 1842 1847 9667656 10.1038/bjc.1998.306 1:STN:280: DyaK1czjtVagsg%3D%3D
26. FL Greene LH Sobin 2008 The staging of cancer: a retrospective and prospective appraisal CA Cancer J Clin 58 3 180 190 18460593 10.3322/CA.2008.0001
27. Cavallo F, De GC, Nanni P, Forni G, Lollini PL. 2011: the Immune Hallmarks of Cancer. Cancer Immunol Immunother 2011; 60(3): 319-26
28. MG von Herrath LC Harrison 2003 Antigen-Induced regulatory T cells in autoimmunity Nat Rev Immunol 3 3 223 232 10.1038/nri1029
29. W Zou 2006 Regulatory T cells, tumour immunity and immunotherapy Nat Rev Immunol 6 4 295 307 16557261 10.1038/nri1806 1:CAS:528:DC%2BD28XivVyru7k%3D